Last reviewed · How we verify
Mucotra SR Tablet 150mg
At a glance
| Generic name | Mucotra SR Tablet 150mg |
|---|---|
| Also known as | Mucotra |
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
- Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mucotra SR Tablet 150mg CI brief — competitive landscape report
- Mucotra SR Tablet 150mg updates RSS · CI watch RSS
- Daewoong Pharmaceutical Co. LTD. portfolio CI